Advanced search
Publication Cover
International Journal of Hyperthermia Volume 37, 2020 - Issue 1
Submit an article Journal homepage
2,209
Views
4
CrossRef citations to date
0
Altmetric
Article

Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis

Shuanggang Chena Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Mengting Shib People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Lujun Shena Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Han Qia Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Weiqi Wanb People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Fei Caoa Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Lin Xiea Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Ying Wua Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Guanjian Chenb People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Jinqing Mob People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Guolian Zhub People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;d Department of Oncology, Chenghai District People’s Hospital, Shantou, People’s Republic of ChinaView further author information
,
Dongdong Yeb People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Yinqi Zhangb People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Ziqing Fengb People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;c Zhong Shan Medical School, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Li Xub People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China;e Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Weijun Fana Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;b People’s Republic of China State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 384-391 | Received 19 Dec 2019, Accepted 31 Mar 2020, Published online: 23 Apr 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhaonan Li & Xinwei Han. (2020) Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020. International Journal of Hyperthermia 37:1, pages 1312-1312.
Read now

Articles from other publishers (3)

Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi & David M. Liu. (2023) Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 115, pages 102526.
Crossref
Shen Zhang, Wan-Sheng Wang, Bin-Yan Zhong & Cai-Fang Ni. (2022) Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence. Journal of Clinical and Translational Hepatology 10:4, pages 740-747.
Crossref
Shen Zhang, Bin-Yan Zhong, Lei Zhang, Wan-Sheng Wang & Cai-Fang Ni. (2022) Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition. World Journal of Gastrointestinal Surgery 14:6, pages 528-537.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.